Dextro-transposition of the great arteries corrective surgery
(Redirected from Corrective surgery)
|
Dextro-transposition of the great arteries Microchapters |
|
Differentiating dextro-transposition of the great arteries from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Dextro-transposition of the great arteries corrective surgery On the Web |
|
American Roentgen Ray Society Images of Dextro-transposition of the great arteries corrective surgery |
|
FDA on Dextro-transposition of the great arteries corrective surgery |
|
CDC on Dextro-transposition of the great arteries corrective surgery |
|
Dextro-transposition of the great arteries corrective surgery in the news |
|
Blogs on Dextro-transposition of the great arteries corrective surgery |
|
Risk calculators and risk factors for Dextro-transposition of the great arteries corrective surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
Overview
Recent advances in surgical correction of transposition of the great arteries have reduced the mortality drastically from 95% in uncorrected patients to 5% in corrected patients[1].
{{#ev:youtube|sqfMNwEagWw}}
General features
Arterial switch or Jatene Operation
Atrial switch repair
Rastelli operation
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[2][3]
Evaluation of the Operated Patient With Dextro-Transposition of the Great Arteries (DO NOT EDIT)[2][3]
| Class I |
| "1. Patients with repaired d-TGA should have annual follow-up with a cardiologist who has expertise in the management of ACHD patients. (Level of Evidence: C)" |
After Atrial Baffle Procedure (Mustard, Senning) (DO NOT EDIT)[2][3]
| Class I |
| "1. Surgeons with training and expertise in congenital heart disease (CHD) should perform operations in patients with d-TGA and the following indications: |
| a. Moderate to severe systemic (morphological tricuspid) AV valve regurgitation without significant ventricular dysfunction. (Carrel & Pfammatter, 2000) (Level of Evidence: B) |
| b. Baffle leak with left-to-right shunt greater than 1.5:1, right to-left shunt with arterial desaturation at rest or with exercise, symptoms, and progressive ventricular enlargement that is not amenable to device intervention. (Level of Evidence: B) |
| c. Superior vena cava or inferior vena cava obstruction not amenable to percutaneous treatment. (Level of Evidence: B) |
| d. Pulmonary venous pathway obstruction not amenable to percutaneous intervention. (Level of Evidence: B) |
| e. Symptomatic severe subpulmonary stenosis. (Level of Evidence: B)" |
After Arterial Switch Operation (DO NOT EDIT)[2][3]
| Class I |
| "1. It is recommended that surgery be performed in patients after the ASO with the following indications: |
| a. RVOT obstruction peak-to-peak gradient greater than 50 mm Hg or right ventricle/left ventricle pressure ratio greater than 0.7, not amenable or responsive to percutaneous treatment; lesser degrees of obstruction if pregnancy is planned, greater degrees of exercise are desired, or concomitant severe pulmonary regurgitation is present. (Level of Evidence: C) |
| b. Coronary artery abnormality with myocardial ischemia not amenable to percutaneous intervention. (Level of Evidence: C) |
| c. Severe neoaortic valve regurgitation. (Level of Evidence: C) |
| d. Severe neoaortic root dilatation (greater than 55 mm) after ASO. (Coady et al., 1999) (This recommendation is based on data for other forms of degenerative aortic root aneurysms). (Level of Evidence: C)" |
After Rastelli Procedure (DO NOT EDIT)[2][3]
| Class I |
| "1. Reoperation for conduit and/or valve replacement after Rastelli repair of d-TGA is recommended in patients with the following indications: |
| a. Conduit obstruction peak-to-peak gradient greater than 50 mm Hg. (Level of Evidence: C) |
| b. RV/LV pressure ratio greater than 0.7. (Level of Evidence: C) |
| c. Lesser degrees of conduit obstruction if pregnancy is being planned or greater degrees of exercise are desired. (Level of Evidence: C) |
| d. Subaortic (baffle) obstruction (mean gradient greater than 50 mm Hg). (Level of Evidence: C) |
| e. Lesser degrees of subaortic (baffle) obstruction if LV hypertrophy is present, pregnancy is being planned, or greater degrees of exercise are desired. (Level of Evidence: C) |
| f. Presence of concomitant severe aortic regurgitation (AR). (Level of Evidence: C)" |
| "2. Reoperation for conduit regurgitation after Rastelli repair of d-TGA is recommended in patients with severe conduit regurgitation and the following indicators: |
| a. Symptoms or declining exercise tolerance. (Level of Evidence: C) |
| b. Severely depressed RV function. (Level of Evidence: C) |
| c. Severe RV enlargement. (Level of Evidence: C) |
| d. Development/progression of atrial or ventricular arrhythmias. (Level of Evidence: C) |
| e. More than moderate tricuspid regurgitation (TR). (Level of Evidence: C)" |
| "3. Collaboration between surgeons and interventional cardiologists, which may include preoperative stenting, intraoperative stenting, or intraoperative patch angioplasty with or without conduit replacements, is recommended to determine the most feasible treatment for pulmonary artery stenosis.(Level of Evidence: C)" |
| "4. Surgical closure of residual VSD in adults after Rastelli repair of d-TGA is recommended with the following indicators: |
| a. Pulmonary blood flow/systemic blood flow (Qp/Qs) greater than 1.5:1. (Level of Evidence: B) |
| b. Systolic pulmonary artery pressure greater than 50 mm Hg. (Level of Evidence: B) |
| c. Increasing LV size from volume overload. (Level of Evidence: C) |
| d. Decreasing RV function from pressure overload. (Level of Evidence: B) |
| e. RVOT obstruction (peak instantaneous gradient greater than 50 mm Hg). |
| f. Pulmonary artery pressure less than two thirds of systemic pressure, or PVR less than two thirds of systemic vascular resistance, with a net left-to-right shunt of 1.5:1, or a decrease in pulmonary artery pressure with pulmonary vasodilators (oxygen, nitric oxide, or prostaglandins). (Level of Evidence: B)" |
| "5. Surgery is recommended after Rastelli repair of d-TGA in adults with branch pulmonary artery stenosis not amenable to percutaneous treatment. (Level of Evidence: C)" |
| "6. In the presence of a residual intracardiac shunt or significant systemic venous obstruction, permanent pacing, if indicated, should be performed with epicardial leads. (Carrel & Pfammatter, 2000) (Level of Evidence: B)" |
| Class IIa |
| "1. A concomitant Maze procedure can be effective for the treatment of intermittent or chronic atrial tachyarrhythmias in adults with d-TGA requiring reoperation for any reason.(Level of Evidence: C)" |
References
- ↑ Hutter PA, Kreb DL, Mantel SF, Hitchcock JF, Meijboom EJ, Bennink GB (2002). "Twenty-five years' experience with the arterial switch operation". J Thorac Cardiovasc Surg. 124 (4): 790–7. PMID 12324738.
- ↑ 2.0 2.1 2.2 2.3 2.4 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease)". Circulation. 118 (23): 2395–451. doi:10.1161/CIRCULATIONAHA.108.190811. PMID 18997168.
- ↑ 3.0 3.1 3.2 3.3 3.4 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.